| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MYGN | Common Stock | Award | $15,462 | +1,118 | +0.37% | $13.83 | 301,972 | 30 Nov 2024 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | These shares were acquired under the Myriad Genetics, Inc. 2012 Amended and Restated Employee Stock Purchase Plan, in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). |